AI-generated summary
The authors studied blue light glasses (about 470 nm) worn each morning for one week by 15 patients with delayed sleep-wake phase disorder, compared with 15 healthy controls. They report improved subjective sleep quality, fewer nighttime awakenings and a shift of sleep timing toward earlier. The abstract also notes that the efficacy findings were correlated with several scales, but it does not describe a control-group treatment comparison in detail.
- Participants
- 30
- Who or what was studied
- Patients with delayed sleep-wake phase disorder (15) and healthy controls (15)
- Wavelengths
- 470 nm
- Limits stated in the abstract
- The abstract describes a small sample, a one-week treatment period and no randomized comparison arm, so the findings are preliminary.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 470 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Control group, Depression, Wavelength, Insomnia, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.